Literature DB >> 11697337

Short-course corticosteroid-induced pulmonary and apparent cerebral aspergillosis in a patient with idiopathic thrombocytopenic purpura.

J Apostolidis, M Tsandekidi, D Kousiafes, M Pagoni, C Mitsouli, T Karmiris, M Bakiri, D Karakasis, N Harhalakis, E Nikiforakis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11697337     DOI： 10.1182/blood.v98.9.2875a

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

1.  A novel triple therapy for ITP using high-dose dexamethasone, low-dose rituximab, and cyclosporine (TT4).

Authors:  Philip Young-Ill Choi; Fernando Roncolato; Xavier Badoux; Sundra Ramanathan; Shir-Jing Ho; Beng H Chong
Journal:  Blood       Date:  2015-05-13       Impact factor: 22.113

2.  Prednisone versus high-dose dexamethasone for untreated primary immune thrombocytopenia. A retrospective study of the Japan Hematology & Oncology Clinical Study Group.

Authors:  Kana Sakamoto; Hideki Nakasone; Shigeharu Tsurumi; Ko Sasaki; Kinuko Mitani; Michiko Kida; Akira Hangaishi; Kensuke Usuki; Ayako Kobayashi; Ken Sato; Mariko Karasawa-Yamaguchi; Koji Izutsu; Yasushi Okoshi; Shigeru Chiba; Yoshinobu Kanda
Journal:  J Thromb Thrombolysis       Date:  2014-04       Impact factor: 2.300

3.  Corticosteroid Risk Function of Severe Infection in Primary Immune Thrombocytopenia Adults. A Nationwide Nested Case-Control Study.

Authors:  Guillaume Moulis; Aurore Palmaro; Laurent Sailler; Maryse Lapeyre-Mestre
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.